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Epidermolysis bullosa simplex (EBS) is usually inherited as an autosomal dominant disease due 
to monoallelic gain-of-function mutations in KRT5 and KRT14. Although autosomal recessive 
forms of EBS have been associated with mutations in at least 10 genes, recessive EBS due to 
homozygous biallelic KRT5 mutations has not been reported previously; it has been hypothesized 
that it would result in prenatal lethality. We sought the genetic causes of EB in a cohort of 512 
distinct EB patients by performing whole exome sequencing (WES) and using a disease-
targeting next-generation sequencing (NGS) panel of 21 genes. The pathogenicity and 
consequences of the mutations were determined by expression profiling and at tissue and 
ultrastructural levels. Two pathogenic, homozygous missense variants of KRT5 in two patients 
with generalized EBS and a homozygous null mutation in a patient who died as a neonate from 
complications of EB were found. The two missense mutations disrupted keratin 5 expression on 
immunofluorescence microscopy, and the human “knock-out” of KRT5 showed no RNA and 
protein expression. Collectively, these findings identify biallelic KRT5 mutations with a 
phenotypic spectrum varying from mild, localized and generalized to lethal, expanding the 
genotypic profile of autosomal recessive EBS. 
 








Epidermolysis bullosa (EB), a heterogeneous group of heritable blistering disorders, is 
subdivided into four broad categories on the basis of the topographic location of the blistering 
within the skin. In the simplex type (EBS), the blisters develop within the epidermis, in most 
cases within the basal keratinocytes; in the junctional forms (JEB), tissue separation occurs 
within the dermal-epidermal basement membrane, primarily within the lamina lucida; in the 
dystrophic forms (DEB), tissue separation is below the lamina densa within the upper papillary 
dermis; and in Kindler syndrome (KS) there are multiple levels of blistering within the skin, even 
in biopsies from the same patient [1-4]. Sub-classification of the patients into these four broad 
categories has been helpful in prognostication of the severity and the overall outcome of the 
disease in an individual patient. However, within each of these four categories, there is 
tremendous phenotypic variability which, in part, reflects genetic heterogeneity. There are as 
many as 21 distinct genes which harbor mutations in different families with EB. , and the The 
types of mutations and their consequences at the mRNA and protein levels, when juxtaposed to 
environmental factors, primarily external trauma at the extracellular matrix/cell interface, 
determine the overall severity in the phenotypic spectrum of this disease [2, 4-7].  
 EBS is inherited in most cases in an autosomal dominant pattern, and a large number of 
dominant-negative mutations in the genes, KRT5 and KRT14, which encode basal keratins 5 and 
14, respectively, have been disclosed [8-10]. In addition, autosomal dominant inheritance of EBS 
has been associated with mutations in the KLHL24 gene [11-13] and with a distinct PLEC 
missense variant [14]. In autosomal recessive EBS, approximately 10% of cases have been 
shown to result from mutations in TGM5 encoding transglutaminase 5. In contrast, relatively few 
cases harbor mutations in other genes, including JUP, DSP, PKP1, EXPH5, PLEC, CD151, and 
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DST-e [15]. Some EBS families with the autosomal recessive mode of inheritance have been 
shown to harbor biallelic loss-of-function mutations in KRT14, with the resulting blistering 
phenotype varying from relatively mild to very severe [16]. Up to now, however, no autosomal 
recessive families with homozygous biallelic KRT5 mutations have been reported. 
 In this study we report three consanguineous EBS families with an autosomal recessive 
mode of inheritance, with the probands harboring homozygous KRT5 mutations.  
 
Results 
We investigated the molecular genetics of EB patients in a large cohort of consanguineous 
families by next generation sequencing (NGS) approaches, including the use of a disease-
targeted sequencing panel consisting of 21 skin fragility-associated genes as well as by whole 
exome sequencing (WES) [17-19]. In three consanguineous families, probands were found to 
have skin blistering and erosions since birth, consistent with EB (Fig. 1). The parents were 
clinically unaffected, suggesting autosomal recessive inheritance (Fig. 2). All three patients were 
found to have homozygous KRT5 mutations.  
 
Case Reports 
Family 1: The proband was a 32-year-old female born to first-cousin consanguineous parents of 
Iranian origin with Kurdish ethnicity (Fig. 2a). There was no family history of genetic diseases. 
Cutaneous manifestations included trauma-induced blistering and erosions noted at a few days 
after birth. The blisters were multiple and widespread, and they were particularly severe in the 
plantar aspects of the feet accompanied with plantar keratoderma (Fig. 1). The blisters were often 
hemorrhagic and painful and healed with pruritus. There was delayed wound healing due to 
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infections. The number, size, and the frequency of blisters were exacerbated by exposure to heat. 
In addition, nail dystrophy, subungual bullae leading to traumatic onycholysis and hemorrhage 
followed by nail loss, was reported by the patient. No alopecia was noted or reported. 
Mucosal manifestations included frequent ulcerations affecting all areas of oral mucosa 
including the tongue. She was not able to tolerate the trauma of tooth brushing. The patient 
reported chronic constipation, painful defecation, and fecal impaction. The proband was also 
found to have renal disease, with a history of kidney and urinary tract infections.  
The patient's weight and height were 49 kg and 160 cm, respectively, with a body mass 
index of 20.3. Hematologic workup revealed that hemoglobin, red blood cell count and mean 
corpuscular volume were within the normal limits. Pertinent negative findings included lack of 
musculoskeletal pathology, tracheo-laryngeal disease, cardiac disease, scarring alopecia, corneal 
erosions, and cutaneous or other malignancies. 
 
Family 2: The male proband, the second child of a first-cousin consanguineous Syrian family, 
was first encountered in the clinic at the age of one year (Fig. 2b). Generalized skin blistering 
since birth and occasional involvement of the oral mucous membranes were reported by the 
mother. The older brother and both parents did not show evidence of skin fragility. Bullae, up to 
25 cm2 in size, were observed mainly on the soles and the abdomen. Blisters, once pierced with a 
sterile needle, healed without scarring. The proband, now four years of age, showed regular 
weight gain but slightly delayed psychomotor development.  
 
Family 3: The female proband was born at 40 weeks’ gestation by cesarean section from a 
Syrian mother with a first-cousin consanguineous marriage (Fig. 2c). Her weight at birth was 2.8 
kg. At birth, the patient had extensive skin defects and multiple cutaneous blisters on her feet, 
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legs, hands and right arm (Fig. 1). Her legs and feet were somewhat underdeveloped, and the 
skin was atrophic. Within a few hours after birth, more blisters developed on her trunk, the face, 
and her mouth, and eventually about 80% of the body was affected. These blisters ruptured 
easily. Her hands and feet were swollen, and she seemed to experience pain. She was placed in 
an incubator at the neonatal intensive care unit, an umbilical catheter was inserted, and treatment 
with antibiotics and analgesics was initiated. The skin heeled on some parts of the body, but not 
on the feet and hands. One month after birth, she became lethargic, the urine production 
subsided, her breathing became labored, and she died four weeks after the birth. The mother’s 
sister was born with similar skin manifestations, and she also died shortly after birth. 
 
Whole exome sequencing and NGS panel identified homozygous pathogenic variants in 
KRT5  
We have developed a disease-targeted NGS array consisting of 21 genes associated with skin 
fragility disorders (for the list of genes in the panel, see Materials and Methods). This sequencing 
panel was applied to DNA from 362 probands, each representing a distinct family, with a clinical 
diagnosis of EB, based on history of neonatal blistering and erosions of the skin. NGS, followed 
by bioinformatics analysis, identified in probands of Families 1 and 2 homozygous missense 
variants, NM_000424.4:c.508G>A, p.Glu170Lys; and NM_000424.4:c.472G>A, p.Asp158Asn 
in KRT5, respectively (Fig. 2a, b). These variants were predicted to be pathogenic by 
ANNOVAR software tool by using various prediction programs (including Provean, SIFT, 
PolyPhen-2, Mutation Taster, and Fathmm), and they were not found either in ExAC, 1000 
Genomes, or gnomAD databases of normal populations.  
8 
 
The presence of these mutations at the genomic level was confirmed by PCR, followed 
by bi-directional Sanger sequencing (Fig. 2a,b), and the patients’ clinically unaffected parents 
were shown to be heterozygous carriers of these mutations.  
     In Family 3, the proband was initially diagnosed with a severe form of EB, based on 
cutaneous and oral blistering. For confirmation of her diagnosis, the proband's DNA was 
submitted to WES, which identified a total of 88,210 sequence variants (Fig. 2dc). Following 
bioinformatics filtering, which considered exonic/splicing variants only, removed synonymous 
and benign sequence variants, and identified homozygous variants with minor allelic 
frequency (MAF) <0.001, reduced the number of annotated, potentially pathogenic variants to 20 
(Fig. 2dc; for the complete list, see Table S1).  
For elucidation of the degree of homozygosity from the WES data, Binary Alignment 
Map (BAM) files were converted to Variant Call Format (VCF) format, and VCF files were used 
as an input for PLINK (see Materials and Methods). The total amount of regions of 
homozygosity (ROH) identified in the proband was 220 Mb (out of the total autosome of 2,850 
Mb) or about 7.8 percent. This percentage is consistent with the parents’ reported first cousin 
relationship and reflects the extensive practice of consanguinity in the extended family. 
Potentially pathogenic variants overlapping with ROHs in the proband reduced the number of 
variants to 7 (Fig. 2d), and a recessive homozygous base substitution variant 
KRT5:NM_000424.4:c.1440-1G>A was discovered when the candidate genes were matched 
with the phenotype. This homozygous KRT5 mutation resided within a 22.3 Mb ROH in 
chromosome 12 (Fig. 2e). Thus, this ROH harboring the candidate gene KRT5 provided 
additional evidence for causality of KRT5 mutations for this lethal form of EB. This mutation, 

















This variant was confirmed by bidirectional Sanger sequencing as homozygous in the proband 
(Fig. 2c2f). The parents, clinically unaffected, were heterozygous carriers of the corresponding 
mutation. The allele frequency of this mutation in 249,994 genomes in different populations was 
0.  
 
Consequences of the KRT5 splicing variant at expression level 
To further identify the effects of the KRT5: c.1440-1G>A variant on the level of mRNA 
expression and the splicing pattern of KRT5, whole-transcriptome profiling was performed by 
RNA-Seq with RNA isolated from the keratinocytes of the proband in comparison to six 
controls. Examination of the Sashimi plots revealed retention of intron 7 sequences in the mutant 
mRNA. Thus, the canonical splice site mutation in KRT5 results in altered splicing predicted to 
cause aberrant mRNA and nonsense-mediated mRNA decay, as reflected by the reduced levels 
of the corresponding transcript, as visualized by heat-map analysis (Fig. 2g,hc). Western blotting 
of protein synthesized by keratinocytes established from the skin of the patient showed markedly 
reduced levels of keratin 5, when compared to an unaffected control (Fig. 2c2i). It should be 
noted that the polyclonal antibody used for Western blotting also reacts with keratin 6 which 
may explain the faint, but detectable, signal in the patient. The monoclonal antibody which 
yielded completely negative staining for keratin 5 in immunostaining (see below), does not work 
well in Western blotting. 
 
Consequences of the KRT5 mutations on skin ultrastructure 
Histopathology of perilesional skin from the Proband 1 revealed separation of the epidermis 






(Fig. 3a) which was confirmed by transmission electron microscopy (Fig. 3b). Adjacent to areas 
of blistering, aggregation of some keratin filaments was also noted (Fig. 3c), and the architecture 
of the intermediate filaments was perturbed with an unusual radial configuration of the keratin 
fibers (Fig. 3d). In the skin of the mother of the proband, some basal keratinocytes showed 
compacted basket-weave patterning, while in the heterozygous father’s skin, the basal keratin 
filaments appeared condensed (Fig. 3e,f). Based on these observations, it was concluded that the 
proband has a form of EBS with basal keratin filament disruption, while the clinically unaffected 
parents demonstrated more subtle, slightly abnormal ultrastructural changes in the keratin 
intermediate filament network architecture within the basal keratinocytes.  
 Immunofluorescence of the proband’s skin in Family 1 revealed expression of keratin 5 
and keratin 14 both in the roof and the floor of a blister at the lower pole of the epidermis (Fig. 
4a,d). In the epidermis of the proband’s father, the keratin 5 and 14 distribution appeared normal, 
but the intensity of immunofluorescence was somewhat reduced compared to healthy, unrelated 
controls (Fig. 4b,c,e,f), however, no evidence of blistering was noted. Thus, these findings in the 
patient are consistent with an autosomal recessive form of EBS due to a homozygous missense 
mutation in keratin 5; the findings in the father are not specific beyond indicating slightly 
reduced immunoreactivity for keratins 5 and 14. 
In Family 2, keratin 5 and keratin 14 staining in the KRT5:p.Asp158Asn homozygous 
individual revealed an irregular appearance of labeling (Figure 4). In Family 3, 
immunofluorescence staining for keratin 14 demonstrated normal levels of expression both in the 
roof and the floor of an epidermal blister. However, in contrast, staining for keratin 5 was 
entirely negative indicating absence of this keratin, fully in keeping with the proband being a 





We have characterized three families with biallelic homozygous KRT5 mutations with intra-
epidermal blistering. In the proband of Family 3, the splicing mutation when homozygous 
resulted in complete absence of keratin 5, as determined by immunofluorescence staining, and 
this patient therefore can be considered to be a human “knock-out” of the KRT5 gene. In Family 
2, the proband was homozygous for a missense mutation, p.Asp158Asn, in KRT5, the clinically 
unaffected parents being heterozygous carriers of the mutation. Since the parents did not display 
any clinical findings related to EB, this missense mutation can be considered as a cause of an 
autosomal recessive form of EBS. The proband in Family 1 was homozygous for a KRT5 
missense mutation: p.Glu170Lys, and the parents were heterozygous carriers of this mutation. 
While the parents showed electron microscopic evidence of perturbed intermediate filament 
assembly in the basal keratinocytes, they did not show, under normal living conditions, clinical 
manifestations of EBS, although strenuous and prolonged walking was reported by them to result 
in mild blistering of the feet. Since this mutation, when heterozygous, resulted only in a 
subclinical phenotype, this mutation can also be considered to be recessive, manifesting as overt 
EBS only when present in both alleles.  
 Previously, homozygous or compound heterozygous KRT14 mutations have been 
reported in an apparently autosomal recessive form of EBS [20-24]. In addition, we have 
recently provided evidence of semi-dominant inheritance in a family with a KRT14 missense 
mutation [25]. In the latter family, the patients homozygous for the mutation demonstrated much 
more severe disease than the family members with monoallelic mutation. For KRT5, to the best 
of our knowledge, no patients with homozygous biallelic mutations have been reported. 
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However, Yasukawa et al. (2002) reported a family in which the proband was compound 
heterozygous for KRT5 mutations p.Glu170Lys and p.Glu418Lys [26]. The first mutation, which 
is the same as discovered in our Family 1, was shown in their study to be associated with mild 
blistering phenotype when monoallelic and was considered to be autosomal dominant. In our 
study, the p.Glu170Lys mutation, when monoallelic, resulted in subclinical blistering and was 
designated as an autosomal recessive variant. The differences in the phenotypic expression of 
this mutation in the two families may reflect influence of modifier genes on the different 
ancestral background of these patients (Japanese vs. Iranian). The second mutation in the family 
reported by Yasukawa et al. (2002), p.Glu418Lys, was clearly recessive as the heterozygous 
carriers did not show any evidence of blistering. Thus, these authors interpreted their proband to 
display dominant and recessive compound heterozygous mutations in EBS. Similar combinations 
of dominant and recessive mutations in COL7A1 and COL17A1 genes have also been reported in 
families with DEB and JEB, respectively [27-29]. 
 Among the 21 mutant genes associated with EB, several of them have been shown to 
harbor biallelic recessive null mutations, including our new demonstration of KRT5. 
Individually, these human “knock-outs” provide insight into the specific contributions these 
particular proteins provide physiologically to the prevention of blister formation in the skin, and 
they collectively underscore the molecular complexity in maintaining cell adhesion and integrity 
in human skin. The results also highlight the unmet medical needs for treatment of various forms 
of EB and propose novel personalized approaches for development of efficacious therapies for 
this group of disorders [30] 
 




This study was approved by the Institutional Review Board of the Pasteur Institute of Iran, and 
the Ethics Committee of the University of Freiburg. All subjects and the parents of children gave 
written informed consent to participate in research and to publish their image. A total of 512 
families, including 362 from Iran, were subjected to mutational analysis. The criterion for study 
inclusion was a tentative diagnosis of epidermolysis bullosa (EB) based on history of neonatal 
cutaneous blistering suggestive of a genetic skin fragility disorder. Three patients were found to 
have a trauma-induced blistering due to homozygosity of KRT5. 
 
Whole exome sequencing 
DNA was extracted from peripheral blood lymphocytes of the proband by salting out method. 
DNA concentration was measured using a Qubit 3.0 fluorometer (Life Technologies, Carlsbad, 
CA, USA). The qualified genomic DNA samples were randomly fragmented by Covaris, and the 
size of the library fragments was distributed predominantly between 150 and 200 base pairs (bp). 
Adapters were ligated to both ends of the resulting fragments. The adapter-ligated templates 
were purified by the Agencourt AMPure SPRI beads and fragments with insert size about 176 bp 
were excised. Extracted DNA was amplified by ligation-mediated PCR (LM-PCR), purified, and 
hybridized to the SureSelect Biotinylated RNA Library for enrichment. The hybridized 
fragments were bound to strepavidin beads whereas non-hybridized fragments were washed out 
after 24 h. Captured LM-PCR products were subjected to Agilent 2100 Bioanalyzer to estimate 
the magnitude of enrichment. Each captured library was then loaded on HiSeq2000 platform, and 
high-throughput sequencing for each captured library was performed to ensure that each sample 
met the desired average sequencing depth. 
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Raw image files were processed by Illumina Software 1.7 for base-calling with default 
parameters, and the sequences of each individual were generated as 90/100 bp pair-end reads. 
The bioinformatics analysis was applied to the sequencing data (“raw data”) which was 
generated from the Illumina pipeline. First, the adapter sequence in the raw data was removed, 
and low-quality reads with too many uncertain nucleotide reads or low base quality were 
discarded. This step produced the “clean data”. Secondly, Burrows-Wheeler Aligner (BWA) was 
used for alignment. Read groups were added, duplicates were marked, and the reads were sorted 
using Picard (http://broadinstitute.github.io/picard). After these processes, the final BAM files 
were used for variant calling using the GATK haplotype caller to identify both single nucleotide 
variants (SNVs) and indels. Candidate variants were then annotated using ANNOVAR software. 
ANNOVAR MetaSVM scores, based on several predictive bioinformatics tools, including SIFT, 
PolyPhen2, MutationTaster and MutationAssessor, were used to identify variants as deleterious. 
 
Variant interpretation 
Single nucleotide variants and copy number variants were examined using the annotated CSV 
files of WES from the proband. The sequence variants were filtered from the VCF files for 
missense, nonsense, and splice site-affecting variants. Indel variants were filtered for exonic in-
frame insertions and deletions, frameshift mutations, and gained-lost start or stop codon. 
Additionally, only variants with 1000 Genomes database total frequencies of <0.001, or those 
without frequency data available, were examined. These variants were then overlapped with 
regions of homozygosity (ROH) in the patient. Considering the given phenotype, segregation 
analysis in the family, and the presence of several ROH in the patient with consanguineous 





For elucidation of ROH from the WES data, BAM file was converted to VCF format and used as 
an input for PLINK (http://pngu.mgh.harvard.edu/).  
The Runs of Homozygosity algorithm in PLINK was used to identify ROH. The PLINK default 
values are appropriate for finding large segments of ROH present on dense genotyping platforms 
and were unchanged during the analysis. The PLINK output was filtered to eliminate ROH 
<4 Mb. (For technical details of homozygosity mapping) [31, 32]. 
 
Transcriptome profiling of keratin gene expression by heatmap analysis 
Total RNA was extracted from the keratinocytes obtained from the Patient 3 and six healthy 
controls using TRIzol® Reagent and quantified on a Nanodrop ND-100 spectrophotometer 
(Thermo Fisher Scientific, Wilmington, DE), followed by RNA quality assessment on an Agilent 
2200 TapeStation (Agilent Technologies, Palo Alto, CA). Multiplexed library construction, 
workflow analysis, and sequencing runs were performed following standard Illumina protocols 
(Illumina, Inc., San Diego, CA) using the TruSeq Stranded Total RNA kit with indexes from Set 
A (Cat #: RS-122-2301). Paired-end (2 × 75) sequencing reads were generated on the Illumina 
NextSeq 500 platform and stored in FASTQ format. FASTQ quality was checked using FastQC, 
and the TruSeq RNA adapter sequences were removed by Trimmomatic. Alignment and 
mapping were performed using STAR-2pass (v. 2.5.3a) [33] with the human reference genome 
(GRCh38/hg38) and GENCODE V27 annotations. In the first pass, an initial alignment was 
executed and the splice junction information was collected. This information was then used for 
the second pass in which the final alignment was performed. The alignments were sorted, read 
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group was added, and the corresponding index was created (using Picard tools). The static 
images of Sashimi plots were generated using the Integrative Genomic Viewer (IGV) [34]. R 
programming language (https://www.r-project.org/) was used to perform the expression analysis 
and plotting to show the distribution range of expression values of several keratins and 
representative housekeeping genes in patients versus six controls. 
 
Western blotting 
Cell lysates were collected from dermal keratinocyte cultures of patient 3 using RIPA lysis 
buffer (Sigma–Aldrich) supplemented with protease (Roche) and phosphatase (Sigma–Aldrich) 
inhibitors and subjected to SDS-PAGE on 10% Bis-Tris gel. Subsequently, proteins were 
transferred to a nitrocellulose membrane and immunolabeled with Anti-Cytokeratin 5 (ab53121) 
Rabbit Polyclonal antibody (1:500, ABCAM) and horseradish peroxidase (HRP) conjugated 
secondary antibody (Cell Signaling Technologies, Danvers, MA, USA). Membranes were 
developed using the SuperSignal West Dura Extended Duration Substrate kit (Thermo Fisher 
Scientific, Life Technologies Europe, Ghent, Belgium) and scanned with the Amersham Imager 
680 (GE Healthcare Life Sciences). Following stripping, the membrane was reprobed with an 
antibody to ERK (Abcam, Cambridge, United Kingdom) in order to check for equal loading. 




Skin sections (5 μm) were air-dried and initially blocked with diluted normal goat serum (Sigma-
Aldrich, Dorset, UK), and then incubated with anti-KRT5/KRT14 antibody diluted 1:10 in 
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phosphate-buffered saline with 30% w/v bovine serum albumin (anti-cytokeratin 14 antibody, 
LL002, ABCAM; anti-cytokeratin 5 antibody, XM26, ABCAM; anti-cytokeratin 5 & 6 antibody, 
D5/D6 B4, ABCAM). After washing in phosphate-buffered saline, slides were labeled with 
fluorescein isothiocyanate secondary antibodies (Invitrogen, Paisley, UK). Negative controls 
omitting the primary antibody were also performed. All sections were photographed using the 
same camera and identical exposure times (three seconds).  
 
Transmission electron microscopy 
Skin biopsy specimens were cut into small pieces (<1 mm3) and fixed in half-strength Karnovsky 
fixative for 4 h at room temperature. After washing in 0.1 M phosphate buffer (pH 7.4), the 
samples were immersed in 1.3% aqueous osmium tetroxide (TAAB Laboratories, Berkshire, 
UK) for 2 h, followed by incubation in 2% uranyl acetate (Bio-Rad, Hertfordshire, UK), 
dehydrated in a graded ethanol series, and then embedded in epoxy resin via propylene oxide 
(TAAB Laboratories). Ultra-thin sections were stained with uranyl acetate and lead citrate and 
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Figure 1. Clinical presentation of probands with homozygous biallelic KRT5 mutations. (a) 
The Patient 1, a 32-year-old female, presented with widespread trauma-induced cutaneous 
blisters since birth. The blisters were particularly severe in the plantar aspects of the feet 
accompanied with plantar keratoderma. (b) The Patient 2, a male at the age of one year, 
characterized by generalized skin blistering since birth. (c) The Patient 3, a neonate with severe 
generalized EBS presented with fragile skin and mucosa. Milia was present at one week of life. 
The patient died shortly after birth.  
 
Figure 2. Identification of biallelic KRT5 mutations confirmed the diagnosis of autosomal 
recessive EBS. Pedigrees of the families 1 (a), family 2 (b), and family 3 (c), with 
probands indicated by arrowheads, revealed consanguinity. Sanger sequencing of the proband’s 
DNA confirmed the presence of homozygous biallelic missense mutations in KRT5 
21-gene panel. (d) WES identified 88,210 annotated variants in 
the Patient 3 which were filtered by steps indicated, resulting in identification of a homozygous 
mutation in KRT5. (f) Sanger sequencing confirmed the mutation. (e) Homozygosity mapping 
revealed that the KRT5 gene resides within a 22.3 Mb ROH (blue blocks) in chromosome 12. 
(g) Heatmap visualization of transcriptome analysis revealed markedly reduced level of KRT5 
expression in comparison to other keratin genes, other genes associated with EB phenotypes and 
randomly selected housekeeping genes. 
(h) Sashimi plot of the transcriptome profile of the mutant KRT5 mRNA 




Western blot revealed markedly reduced levels of keratin 5 in keratinocytes isolated from the 
skin of Patient 3 
 
Figure 3: Skin electron microscopy reveals low level intra-epidermal cleavage and keratin 
filament abnormalities. (a) Semithin sections of skin from Patient 1 with homozygous KRT5 
mutation reveal blister formation (asterisk) close to the dermal-epidermal junction; (b) 
Ultrastructurally, the plane of cleavage (asterisk) is within the lower pole of basal keratinocytes, 
with fragments of basal cells present in the blister base (arrow); (c) Within basal keratinocytes 
there is blister formation (asterisk) and aggregation of some keratin filaments (arrow); (d) In 
some basal keratinocytes, the architecture of the intermediate filaments is perturbed (arrows), 
with a more radial configuration of the keratin rather than a concentric perinuclear configuration; 
(e) In the heterozygous mother’s skin, some basal keratinocytes show a compacted basket-weave 
pattern (arrow); (f) In the heterozygous father’s skin the basal keratin filaments appear 
condensed (arrow) in some basal keratinocytes. 
 
Figure 4: Immunofluorescence microscopy reveals alterations in basal keratin labeling 
patterns.  Upper panel (a) Keratin 5 staining in patient 1 with the homozygous 
KRT5:p.Glu170Lys mutation reveals an irregular, slightly punctate appearance of labeling within 
the lower epidermis as well keratin 5 mapping to the base and roof of blister (asterisks); (b) In 
the heterozygous father, there is also some irregularity and unevenness to the keratin 5 staining 
in the lower epidermis with slightly reduced overall immunoreactivity; (c) Control skin labeling 
for keratin 5 reveals even intracellular staining in the lower epidermis particularly in basal 
keratinocytes; (d) Keratin 14 staining in the homozygous individual with KRT5 mutation reveals 
26 
 
an irregular appearance to labeling within the lower epidermis as well keratin 14 mapping to the 
base and roof of a blister (asterisks); (e) In the heterozygous father, there is also some 
irregularity and unevenness to the keratin 14 staining in the lower epidermis and slightly reduced 
immunoreactivity; (f) Control skin labeling for keratin 14 reveals even intracellular staining in 
the lower epidermis particularly in basal keratinocytes. (g and h) Keratin 5 and keratin 14 
staining in the homozygous KRT5:p.Asp158Asn proband (patient 2) reveals an irregular 
appearance to labelling. (i and j). In the homozygous KRT5: c.1440-1G>A proband (patient 3), 
keratin 5 is essentially absent, and keratin 14 staining shows cleavage within the basal 
keratinocytes. (k and l) The panels show control skin labeling for keratin 5 and 14 with even 
intracellular staining in the lower epidermis, particularly in basal keratinocytes. Scale bar = 50 
µm. 
 
 
 
